Pain News and Research

Latest Pain News and Research

Could statins treat muscular dystrophy? An interview with Dr. Nick Whitehead and Dr Stan Froehner

In addition to their well established cholesterol lowering benefits, statins also have potent anti-inflammatory, anti-fibrotic and antioxidant effects, which continue to be identified in a wide range of diseases.

30 Nov 2015

Korean MFDS approves InSightec's Exablate Neuro system to treat movement, pain and behavioral disorders

Elbit Imaging Ltd. announced today that it was informed by InSightec Ltd., that the Korean Ministry of Food and Drug Safety has approved its Exablate Neuro system to treat movement, pain and behavioral disorders.

30 Nov 2015

Weight loss can slow degeneration of knee cartilage in obese people

Obese people who lose a substantial amount of weight can significantly slow the degeneration of their knee cartilage, according to a new MRI study presented today at the annual meeting of the Radiological Society of North America.

30 Nov 2015

Personalised peptide vaccination promising in bladder cancer

Metastatic bladder cancer patients who have progressed on first-line platinum-based chemotherapy could derive survival benefits from personalised peptide vaccination, according to phase II trial results.

27 Nov 2015

Cognitive behavioural therapy benefits people with dental phobia

Cognitive behavioural therapy could help many people with a dental phobia overcome their fear of visiting the dentist and enable them to receive dental treatment without the need to be sedated, according to a new study by King's College London.

27 Nov 2015

New test can detect drug abuse faster

A new test for club drugs like ketamine can detect low levels of drugs in urine and plasma, making it faster, easier and cheaper to identify them. The authors of the study, published in Journal of Chromatography B, say it could give authorities the boost they need to keep up with trends drug (ab)use.

26 Nov 2015

Columbia University data scientists create world's first catalog of therapeutic venom

What doesn't kill you could cure you. A growing interest in the therapeutic value of animal venom has led a pair of Columbia University data scientists to create the first catalog of known animal toxins and their physiological effects on humans.

26 Nov 2015

Chikungunya may cause severe brain infection

The mosquito-borne virus chikungunya may lead to severe brain infection and even death in infants and people over 65, according to a new study that reviewed a chikungunya outbreak on Reunion Island off the coast of Madagascar in 2005-2006.

26 Nov 2015

Study sheds new light on the controversy surrounding common osteoarthritis treatment

Injections of hyaluronic acid (HA) are a common treatment of pain in osteoarthritis of the knee - a condition that affects 27 million Americans according to the Centers for Disease Control and Prevention. The injections replace natural HA that has depleted from one's joints, which can cause pain and stiffness due to the lack of lubrication between bones moving against each other.

26 Nov 2015

New doctoral thesis reveals potential treatment for stress-induced cardiomyopathy

Stress induced cardiomyopathy after cerebral hemorrhage has been shown to increase the risk of further brain damage. These patients can now be identified by a simple blood test, and a possible treatment for stress induced cardiomyopathy has been discovered - a different kind of anesthesia than that currently being used. A new doctoral thesis at Sahlgrenska Academy has explored these issues.

26 Nov 2015

Delaying stereotactic radiosurgery worsens trigeminal neuralgia pain outcomes

Stereotactic radiosurgery, as a first surgical procedure for medically refractory trigeminal neuralgia, should be performed within 3 years of pain onset to achieve the best results, researchers recommend.

25 Nov 2015

Orthopedic surgeon creates world's first internal bone-lengthening device for young children

An orthopedic surgeon is creating the world's first implantation device that can lengthen the bones of young children internally. The inventor, a physician at Texas Tech University Health Sciences Center El Paso, expects the device will lead to fewer infections and less pain, making the bone-lengthening process more bearable for children.

25 Nov 2015

Seqirus announces FDA approval of Fluad for seasonal influenza

Seqirus announced today that the US Food and Drug Administration has approved Fluad (Influenza Vaccine, Adjuvanted) to help protect those aged 65 years and older against seasonal influenza. Fluad is the first adjuvanted seasonal influenza vaccine approved in the United States; it was specifically developed for the adult population aged 65 and older.

25 Nov 2015

People with chronic fatigue syndrome could experience higher levels of visual stress

People suffering from Chronic Fatigue Syndrome (CFS) could experience higher levels of visual stress than those without the condition, according to new research from the University of Leicester.

25 Nov 2015

Novartis announces EC approval of Cosentyx for treatment of ankylosing spondylitis, psoriatic arthritis

Novartis announced today that the European Commission has approved Cosentyx (secukinumab) for the treatment of people living with ankylosing spondylitis (AS) and psoriatic arthritis (PsA). For AS, this is the first new treatment advance in 16 years since the development of the current standard of care, anti-tumor necrosis factor (anti-TNF) therapy.

25 Nov 2015

First seasonal influenza vaccine containing adjuvant now approved by FDA

The U.S. Food and Drug Administration today approved Fluad, the first seasonal influenza vaccine containing an adjuvant. Fluad, a trivalent vaccine produced from three influenza virus strains (two subtype A and one type B), is approved for the prevention of seasonal influenza in people 65 years of age and older.

25 Nov 2015

New study finds evidence to support meperidine-associated seizure risk

Meperidine, an opioid analgesic commonly used to control shivering in accidental or therapeutic hypothermia, has been linked to increased seizure risk, but a new study finds little published evidence to support this risk.

24 Nov 2015

BioThrax approved to prevent disease after exposure to anthrax spores

The U.S. Food and Drug Administration today approved a new indication for BioThrax (Anthrax Vaccine Adsorbed) to prevent disease following suspected or confirmed exposure to Bacillus anthracis, the bacterium that causes anthrax disease. The vaccine's new use is approved for people 18 through 65 years of age in conjunction with recommended antibiotic treatment. BioThrax was initially approved by the FDA in 1970 for the prevention of anthrax disease in persons at high risk of exposure.

24 Nov 2015

Opdivo (nivolumab) approved to treat patients with advanced renal cell carcinoma

The U.S. Food and Drug Administration today approved Opdivo (nivolumab) to treat patients with advanced (metastatic) renal cell carcinoma, a form of kidney cancer, who have received a certain type of prior therapy.

23 Nov 2015

People who experience persistent heartburn despite over-the-counter treatments need to check with their doctors

If Thanksgiving makes you wince at the thought of impending heartburn pain, you are probably not alone. But if you experience heartburn more than twice a week despite over-the-counter treatments, a Jefferson expert wants you to check with your doctor. Gastroesophageal Reflux Disease (GERD) Awareness Week is observed each year during the week of Thanksgiving, a fitting time as Americans prepare to indulge in the holiday season.

23 Nov 2015

Pain News and Research

Latest Pain News and Research

Could statins treat muscular dystrophy? An interview with Dr. Nick Whitehead and Dr Stan Froehner

Korean MFDS approves InSightec's Exablate Neuro system to treat movement, pain and behavioral disorders

Weight loss can slow degeneration of knee cartilage in obese people

Personalised peptide vaccination promising in bladder cancer

Cognitive behavioural therapy benefits people with dental phobia

New test can detect drug abuse faster

Columbia University data scientists create world's first catalog of therapeutic venom

Chikungunya may cause severe brain infection

Study sheds new light on the controversy surrounding common osteoarthritis treatment

New doctoral thesis reveals potential treatment for stress-induced cardiomyopathy

Delaying stereotactic radiosurgery worsens trigeminal neuralgia pain outcomes

Orthopedic surgeon creates world's first internal bone-lengthening device for young children

Seqirus announces FDA approval of Fluad for seasonal influenza

People with chronic fatigue syndrome could experience higher levels of visual stress

Novartis announces EC approval of Cosentyx for treatment of ankylosing spondylitis, psoriatic arthritis

First seasonal influenza vaccine containing adjuvant now approved by FDA

New study finds evidence to support meperidine-associated seizure risk

BioThrax approved to prevent disease after exposure to anthrax spores

Opdivo (nivolumab) approved to treat patients with advanced renal cell carcinoma

People who experience persistent heartburn despite over-the-counter treatments need to check with their doctors

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Pain News and Research

Latest Pain News and Research

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in